Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with ...

Scientist Raghu Kalluri reveals innovative early cancer detection methods using exosomes at the SPARC Cancer Research Conclave-II.

EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening ...

Advancing Research, Awareness, and Targeted Youth Advocacy for Women Diagnosed with Breast Cancer Before Age 40 DENVER, ...

Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and genomics ...

Dr. Soon-Shiong joins Nobel laureates, former NIH directors, and leading oncology pioneers in Washington, D.C. to chart a path toward defeating cancer by 2035, with the discussion streamed live at ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology ...

Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...

New innovations designed to simplify NGS workflows Enhances critical variant identification through improved ...

The human lymphatic system is notoriously difficult to map due to its size and variability among individuals. Spatial ...

Gastric cancer remains the fifth leading cause of cancer-related deaths worldwide. Although its overall incidence has declined, early-onset cases-diagnosed before age 50-display unique biological and ...